NCT03514121 2024-11-22FPA150-001Five Prime Therapeutics, Inc.Phase EARLY_PHASE1 Terminated95 enrolled 36 charts
NCT05465590 2023-12-21A Phase 1 Study to Evaluate Paclitaxel Conjugated CXC Receptor 4 Antagonist (MB1707) in Patients With Advanced CancerMainline Biosciences, Inc.Phase EARLY_PHASE1 Withdrawn
NCT05886075 2023-06-02A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid TumorsShanghai Yunying Medical TechnologyPhase EARLY_PHASE1 Unknown24 enrolled
NCT05801783 2023-04-06A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Ovarian CancerShanghai Yunying Medical TechnologyPhase EARLY_PHASE1 Unknown10 enrolled
NCT04503980 2020-08-07αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid TumorsShanghai Cell Therapy Group Co.,LtdPhase EARLY_PHASE1 Unknown10 enrolled